Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Publication year range
1.
Urol Int ; 61(2): 86-9, 1998.
Article in English | MEDLINE | ID: mdl-9873246

ABSTRACT

Recurrence of growth of urinary stone is frequently observed during the clinical course of cystinuria patients. The aim of the present study is to examine the long-term outcome of cystinuria in Japan and clarify the effects of medical treatment on urinary stone. Thirty-one patients with cystinuria who had been followed up longer than 6 months were included. The follow-up period was 6-264 months with a mean of 89.5 months. Stone event was defined as appearance of new stone or radiological evidence of stone growth. All patients were managed with forced hydration and urine alkalization. Twenty-eight patients were treated with administration of thiol such as D-penicillamine or alpha-mercaptopropionylglycine. Stone events per year ranged from 0 to 1.09 with a median of 0.09. Stone events per patient-year was 0.19 for all patients. The average urinary cystine concentration during treatment in the favorable outcome group (stone events per year < 0.3) was lower that that in the unfavorable outcome group (stone events per year >/=0.3); 221.2 +/- 75.2 vs. 303.3 +/- 93.5 mg/l, although the difference was not statistically significant. Prognosis of urinary stone in Japanese patients with cystinuria was relatively good with large variation. The medical treatment to reduce urinary cystine concentration would be useful for the management of cystinuria.


Subject(s)
Chelating Agents/therapeutic use , Cystinuria/drug therapy , Penicillamine/therapeutic use , Tiopronin/therapeutic use , Adult , Cystine/metabolism , Cystinuria/complications , Cystinuria/urine , Female , Follow-Up Studies , Humans , Hydrogen-Ion Concentration , Japan , Male , Recurrence , Treatment Outcome , Urinary Calculi/diagnosis , Urinary Calculi/drug therapy , Urinary Calculi/etiology
5.
Urol Int ; 36(2): 79-87, 1981.
Article in English | MEDLINE | ID: mdl-6169181

ABSTRACT

The binding of dihydrotestosterone, R 1881 and R 5020 was examined in cytosols of normal, benign hypertrophic and cancerous tissues of the human prostates. Almost all samples obtained by open operation showed high affinity binding to these ligands. Dissociation constants of the binding to these ligands were approximately 10(-9) M irrespective of the pathological state of the prostates. Maximum binding sites for dihydrotestosterone seemed to be greater in normal tissues than in the pathological ones. However, maximum binding sites for R 1881 and R 5020 were not significantly different among the normal and pathological prostates examined in the present study. Moreover, some correlation was observed between the maximum binding sites for R 1881 and those for R 5020. The samples resected by TUR seemed to be inadequate for analyses of androgen binding.


Subject(s)
Dihydrotestosterone/metabolism , Estrenes/metabolism , Norpregnadienes/metabolism , Promegestone/metabolism , Prostate/metabolism , Prostatic Hyperplasia/metabolism , Prostatic Neoplasms/metabolism , Cytosol/metabolism , Humans , In Vitro Techniques , Male , Metribolone , Testosterone Congeners/metabolism
6.
Prostate Suppl ; 1: 9-17, 1981.
Article in English | MEDLINE | ID: mdl-6176984

ABSTRACT

Dihydrotestosterone-binding protein in cytosols from human prostates was different from the R1881- and R5020-binding proteins. The R1881- and R5020-binding proteins in the cytosol were very similar and most of the binding sites for R1881 were capable of binding R5020. However, nuclear extracts showed equal binding to dihydrotestosterone and R1881, but not to R5020, suggesting that there might not be a progestin receptor in the human prostate. Maximum binding sites to dihydrotestosterone, R1881, and R5020 in cytosols were very similar among "normal" and pathological prostates except that dihydrotestosterone binding was higher in "normal" prostates than in the pathological ones. Histochemically, R1881-binding was observed in the epithelial cells and in malignant cells, but not in the stroma.


Subject(s)
Androgen-Binding Protein/analysis , Carrier Proteins/analysis , Prostate/analysis , Cell Nucleus/metabolism , Cytosol/analysis , Dihydrotestosterone/metabolism , Estrenes/metabolism , Humans , Male , Metribolone , Promegestone/metabolism , Prostatic Hyperplasia/metabolism , Prostatic Neoplasms/metabolism
7.
Gan ; 71(1): 1-7, 1980 Feb.
Article in English | MEDLINE | ID: mdl-7380131

ABSTRACT

Cell kinetic study was performed using labeled mitosis method to compare growth characteristics of androgen-dependent mouse mammary tumor (SC115), which grows only in males, and its subline (Chiba subline No. 1), which has partially lost its dependency during passages through males and grows also in females, although at a slower rate. The subline, compared to the original tumor, showed higher growth fraction irrespective of whether inoculated into a male or a female. The cell cycle of the subline was faster in males than in femlaes due to acceleration of Gl phase and this trend was reflected in the cell production rate and overall rate of growth. The slower growth in females was restored by the administration of testosterone. However, growth fraction was rather in the inverse relationship with the cell production rate and this fact suggested that androgen-deprived conditions do not support survival of non-cycling cells. Primary effect of androgenic environment on this subline was considered to be the reduced length of Gl phase.


Subject(s)
Androgens/pharmacology , Mammary Neoplasms, Experimental/pathology , Neoplasms, Hormone-Dependent/pathology , Animals , Cell Cycle , Cell Line , Female , Kinetics , Male , Mice , Neoplasm Transplantation , Sex Factors , Transplantation, Homologous
SELECTION OF CITATIONS
SEARCH DETAIL
...